Skip to main content
. 2018 Mar 6;18:259. doi: 10.1186/s12885-018-4104-4

Fig. 4.

Fig. 4

Analysis of adjuvant chemotherapy benefit based on the 6-protein adenocarcinoma (ADC) signature. Kaplan-Meier estimates of overall survival for the patients at stages IB, II and IIIA with or without adjuvant chemotherapy in the good-prognosis (a) and poor-prognosis (b) group was analyzed